Age‐based subgroup analyses pointed out that IBD patients aged ≥18 years displayed notable increases in serum hepcidin levels equivalent to 22.36 ng/mL (95% CI, 2.12, 42.61; p = .030) when compared to healthy individuals. The gene discussed is HAMP; the disease is inflammatory bowel disease.